The global non-opioid pain patches market size is expected to reach USD 1.04 billion by 2026, expanding at a CAGR of 4.6% during the forecast period, according to a new report by Grand View Research, Inc. Some of the key factors driving the market are rising incidence of pain related disorders and the various benefits offered by these patches over other forms of medication used to alleviate acute and chronic pain.
According
to the AAPM, chronic pain affects more individuals than cancer, diabetes, and
coronary heart disease combined in the U.S. Estimates from the American
Chiropractic Association indicate that American citizens spend at least USD 50
billion every year on back-related ailments. These facts are indicative of the
growing need for therapies to alleviate pain globally.
Opioid
medications are usually sought for the treatment of pain and related disorders
despite resulting in dependence and abuse in majority of patients. The rising
addiction to opioid drugs has encouraged many countries to develop alternate
therapies to alleviate discomfort. In November 2017, opioid epidemic in the
U.S. was declared as a national emergency. Thus, demand for safe and effective
therapies that ease the underlying discomfort with reduced adverse effects are
sought by governments, thus accelerating the market growth.
According
to a new study published by Substance Abuse and Mental Health Services
Administration report in 2015, 1 in 3 adults in America were prescribed
painkillers by medical providers. Statistics from the same source also indicate
that these medications were used more than cigarettes, cigars, and smokeless
tobacco combined. Most of these oral medicines fall under the opiate category
are usually more prone to be addictive and used in combination with other
consumables such as alcohol and other drugs. Growing awareness about the
adverse effects associated with these drugs has led to the development of
alternatives such as non-opioid pain patches to deliver the same therapeutic
effect and aid in pain management.
Full Research Report On Non-opioid Pain Patches Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/non-opioid-pain-patches-market
Non-opioid Pain
Patch Market Report Highlights
- Methyl
salicylate patches are expected to gain significant revenue during the
forecast period owing to increase in product penetration and consumer
adoption
- North America
held the largest revenue share due to local presence of major non-opioid
pain patch market players and increasing R&D in the field of pain
management to cater to a rising number of patients
- The Asia
Pacific region is expected to account for the highest CAGR during the
forecast period owing to rise in investments by dominant players in the
region and developments in the pharmaceutical industry in emerging
countries such as India and China
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/non-opioid-pain-patches-market/request/rs1
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment